 character bay novel thromboxan receptor antagonist thromboxan antagonist properti bay o-lepropano acid variou pharmacolog model bay inhibit platelet aggreg collagen platelet-activ factor second wave adp microm human plasma plasma phase adp-induc aggreg platelet aggreg human platelet aggreg oral applic mg bay bay antagon contract rabbit aortic ring vivo bay rabbit arachidon acid collagen-induc thromboembol mg/kg p.o chronic administr bay stroke-pron hypertens rat stroke-rel mortal occurr cerebr hemorrhag result bay activ select competit thromboxan antagonist benefici treatment cardiovascular cerebrovascular diseas